← Back to Search

Multivitamin/Mineral Supplement

Formulation #1 of a multivitamin/mineral supplement for Bioavailability

N/A

Waitlist Available

Research Sponsored by Midwest Center for Metabolic and Cardiovascular Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 24 hours

Awards & highlights

Study Summary

This trial studies how well two forms of a vitamin/mineral supplement work in healthy adults.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Baseline-adjusted geometric mean ratio (GMR) for area under the curve (AUC) from 0 to 2 h for plasma folate

Secondary outcome measures

Concentration of a select nutrient in urine

Maximum concentrations of select nutrients in plasma

Time (in hours) to reach the maximum concentration of select nutrients in plasma

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Formulation #1 of a multivitamin/mineral supplementExperimental Treatment1 Intervention

Subject will receive a single dose of formulation #1 of a multivitamin/mineral supplement

Group II: Formulation #2 of a multivitamin/mineral supplementActive Control1 Intervention

Subject will receive a single dose of formulation #2 of a multivitamin/mineral supplement

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Formulation #1

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Midwest Center for Metabolic and Cardiovascular ResearchLead Sponsor

20 Previous Clinical Trials

828 Total Patients Enrolled

2 Trials studying Bioavailability

52 Patients Enrolled for Bioavailability

Pharmavite LLCIndustry Sponsor

9 Previous Clinical Trials

26,710 Total Patients Enrolled

1 Trials studying Bioavailability

24 Patients Enrolled for Bioavailability

Kevin C Maki, PhDStudy DirectorMB Clinical Research & Consulting

16 Previous Clinical Trials

940 Total Patients Enrolled

2 Trials studying Bioavailability

52 Patients Enrolled for Bioavailability

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals being included in the current clinical trial?

"This research is taking on participants who are below 45 years of age and have crossed the legal threshold for adulthood."

Answered by AI

Who has the credentials to partake in this research experiment?

"To qualify for this clinical experiment, participants must meet certain bioavailability requirements and be within the 18-45 age range. Ultimately, 24 patients will need to be enrolled in the trial."

Answered by AI

Is participation in this research project currently open to participants?

"According to the clinicaltrials.gov database, this clinical trial is presently recruiting participants; its initial posting was on December 23rd 2022 with a recent update of January 23rd 2023."

Answered by AI

What is the maximum number of applicants that may be accepted into this medical experiment?

"Affirmative. Clinicaltrials.gov reports that this clinical trial is actively looking for people to take part, with the original posting occurring on December 23rd 2022 and updated as recently as January 23rd 2023. They are hoping to recruit 24 participants from a singular site."

Answered by AI

What is the intended outcome of this clinical experiment?

"The principal aim of this clinical trial, running from Baseline to 2 hours, is measuring the geometric mean ratio (GMR) for area under the curve from 0 to 2 h (iAUC 0-2h) regarding folate concentration in plasma. Secondary objectives include assessing unadjusted and baseline-adjusted maximum concentrations for select nutrients in plasma; looking at differences between study products with regards to both unadjusted and baseline-adjusted AUC for select nutrients in plasma; determining discrepancies between study products with respect to time taken to reach the peak level of select nutrients in plasma."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement

2022. "Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05646368.